FERMENTALG |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.596 EUR | +0.34% |
|
+1.53% | +97.35% |
| Apr. 12 | Fermentalg: transfer to Euronext Growth on April 16 | CF |
| Apr. 04 | Fermentalg SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 9.8M 10.66M | Sales 2025 * | 16.1M 17.51M | Capitalization | 30.37M 33.04M |
|---|---|---|---|---|---|
| Net income 2024 * | -10M -10.88M | Net income 2025 * | -8M -8.7M | EV / Sales 2024 * | 4.1 x |
| Net Debt 2024 * | 9.8M 10.66M | Net Debt 2025 * | 15.6M 16.97M | EV / Sales 2025 * | 2.86 x |
| P/E ratio 2024 * |
-2.7
x | P/E ratio 2025 * |
-3.49
x | Employees | 70 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.33% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.34% | ||
| 1 week | +1.53% | ||
| Current month | +4.01% | ||
| 1 month | +4.20% | ||
| 3 months | +6.62% | ||
| 6 months | +121.15% | ||
| Current year | +97.35% |
1 week
0.56
0.62
1 month
0.500.67
Current year
0.270.99
1 year
0.210.99
3 years
0.213.50
5 years
0.214.85
10 years
0.219.06
| Managers | Title | Age | Since |
|---|---|---|---|
Pierre Josselin
CEO | Chief Executive Officer | - | 23-05-03 |
| Director of Finance/CFO | - | - | |
| Chairman | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gilles Schang
BRD | Director/Board Member | - | - |
| Chairman | - | - | |
| Director/Board Member | 56 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 0.596 | +0.34% | 16 826 |
| 24-05-27 | 0.594 | -2.62% | 146,411 |
| 24-05-24 | 0.61 | -1.61% | 188,182 |
| 24-05-23 | 0.62 | +9.93% | 238,903 |
| 24-05-22 | 0.564 | -3.92% | 162,400 |
Real-time Euronext Paris, May 28, 2024 at 04:06 am EDT
More quotes
Fermentalg is an expert in the research and bio-industrial exploitation of micro-algae and aims to provide sustainable solutions and innovative products that contribute to the development of healthy, natural and high-performance products. Its business: the development, production and marketing of sustainable solutions and active ingredients derived from microalgae for nutrition, health and the environment. Nutritional lipids, alternative proteins and natural food colorants make up the company's current and future offer.
Calendar
2024-07-13
- Q2 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.594
EUR
Average target price
1
EUR
Spread / Average Target
+68.35%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +97.35% | 32.98M | |
| +67.53% | 63.85B | |
| -0.77% | 41.83B | |
| +43.96% | 40.47B | |
| -10.87% | 27.17B | |
| +13.30% | 26.52B | |
| -22.79% | 18.69B | |
| +4.70% | 12.73B | |
| +24.10% | 12.11B | |
| +27.41% | 12.07B |
- Stock Market
- Equities
- ALGAE Stock
